Analyzing Chinese Patent Medicine Containing Eighteen Incompatible Herbs and Nineteen Herbs of Mutual Antagonism in Medicine Catalogue for National Basic Medical Insurance,Injury Insurance and Maternity Insurance

LI Yi-wen; ZHONG Gan-sheng; LIU Hai-yan; WANG Xi; LIU Jia

您当前的位置：

首页 >

文章列表页 >

Analyzing Chinese Patent Medicine Containing Eighteen Incompatible Herbs and Nineteen Herbs of Mutual Antagonism in Medicine Catalogue for National Basic Medical Insurance,Injury Insurance and Maternity Insurance

更新时间：2024-09-23

- Analyzing Chinese Patent Medicine Containing Eighteen Incompatible Herbs and Nineteen Herbs of Mutual Antagonism in Medicine Catalogue for National Basic Medical Insurance,Injury Insurance and Maternity Insurance
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 19, Issue 9, Pages: 353-357(2013)
- 作者机构：
  
  北京中医药大学基础医学院
- 作者简介：
- 基金信息：
- DOI：
  CLC： R288
- Published：2013
- 稿件说明：
移动端阅览
[1]李怡文,钟赣生,柳海艳,王茜,刘佳.《国家基本医疗保险、工伤保险和生育保险药品目录》含十八反十九畏药对的成方制剂及临床应用分析[J].中国实验方剂学杂志,2013,19(09):353-357.

LI Yi-wen, ZHONG Gan-sheng, LIU Hai-yan, et al. Analyzing Chinese Patent Medicine Containing Eighteen Incompatible Herbs and Nineteen Herbs of Mutual Antagonism in Medicine Catalogue for National Basic Medical Insurance,Injury Insurance and Maternity Insurance[J]. Chinese journal of experimental traditional medical formulae, 2013, 19(9): 353-357.
[1]李怡文,钟赣生,柳海艳,王茜,刘佳.《国家基本医疗保险、工伤保险和生育保险药品目录》含十八反十九畏药对的成方制剂及临床应用分析[J].中国实验方剂学杂志,2013,19(09):353-357. DOI：

LI Yi-wen, ZHONG Gan-sheng, LIU Hai-yan, et al. Analyzing Chinese Patent Medicine Containing Eighteen Incompatible Herbs and Nineteen Herbs of Mutual Antagonism in Medicine Catalogue for National Basic Medical Insurance,Injury Insurance and Maternity Insurance[J]. Chinese journal of experimental traditional medical formulae, 2013, 19(9): 353-357. DOI：

摘要

目的:"十八反、十九畏"是中医临床用药配伍禁忌的重要组成部分

然历代医家对此问题争议颇多

临床报道也屡见不鲜。《医保目录》是由中国人力资源与社会保障部颁布的

指导药品临床合理用药的依据。方法:本文对2009年版《医保目录》中成药部分含十八反、十九畏药对的成方制剂进行整理

分别从这些含反药药对成方制剂的收载情况、反药药对出现频率、处方药味数、剂型用法以及现代临床的应用方面进行了归纳分析。结果:据统计

《医保目录》中成药部分共收录成方制剂987个品种

其中含反药配伍的成方制剂9个

包括含十八反药对的品种5个

含十九畏药对的品种4个。结论:2009年版《医保目录》中成药中含反药药对成方制剂的用药特点

为探讨反药配伍的临床使用规律

指导临床合理安全使用十八反、十九畏提供思路。

Abstract

Objective:Eighteen incompatible herbs and Nineteen herbs of mutual antagonism

the incompatibility between the traditional Chinese medicine（TCM） has had the history of thousands of years so far.Whether Eighteen incompatible herbs and Nineteen herbs of mutual antagonism are incompatibility or not has become one of the hot spot of academia right now.Method:The medicine catalogue for the national basic medical insurance

injury insurance and maternity insurance was issued by the department of social security and Human Resource

which improving the level of clinical use of drugs.Result:According to statistics

there are 987 kinds of patent Chinese medicine products（CPMs） in medicine catalogue for the national basic medical insurance

injury insurance and maternity insurance（2009 Edition）

in which 5 CPMs contain eighteen incompatible herbs and 4 CPMs contain Nineteen herbs of mutual antagonism.Conclusion:This paper analyze CPMs containing Eighteen incompatible herbs and Nineteen herbs of mutual antagonism to offer some elicitation for promoting rational drug use in the clinic.

关键词

Keywords

references

Views

400

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

An Experimental Study on the Effect of Gansui Banxia Decoction with Different Proportions of KANSUI RADIX and GLYCYRRHIZAE RADIX ET RHIZOMA in Malignant Ascites Rats

Discuss on Chinese Patent Medicines Containing Eighteen Incompatible Herbs or Nineteen Mutual Antagonistic Herbs in (,2015)

Related Author

LI Yi-wen

ZHONG Gan-sheng

LIU Hai-yan

WANG Xi

LIU Jia

CHEN Shao-hong

OU Li-na

WANG Hong-lei

Related Institution

No data

AI问答

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰